Royal Philips has announced that it has reached an agreement to acquire the assets of InnerCool Therapies Inc. InnerCool, a wholly-owned subsidiary of Cardium Therapeutics, Inc., will be acquired in an asset purchase transaction for $11.25 million, as well as the transfer of approximately $1.5 million in trade payables.
Trending:
Philips expands emergency healthcare offerings with acquisition of InnerCool Therapies